Company intelligence / Profile preview

Chimera Research Group

Ownership: Private
Development stage: Other

Overview

Chimera Research Group does not conduct clinical trials or develop drugs. It provides independent and actionable investment and trading ideas based on comprehensive fundamental research and analysis for listed companies in the biotech and pharmaceutical sectors. Their coverage focuses on early-stage companies with impending FDA decisions or clinical trial results as well as mid-to-large cap biopharma companies with specific catalysts.

Industry: Consulting

Partnerships

No major pharma/biotech partnerships; operates independently

Beyond the preview

Go deeper on Chimera Research Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chimera Research Group.

Explore the full profile